Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus infection

被引:21
作者
Ikeda, M
Sugiyama, K
Mizutani, T
Tanaka, T
Shimotohno, K
Kato, N
机构
[1] NATL CANC CTR, RES INST, DIV VIROL, CHUO KU, TOKYO 104, JAPAN
[2] YOKOHAMA CITY UNIV, SCH MED, DEPT INTERNAL MED 3, YOKOHAMA, KANAGAWA 232, JAPAN
[3] KYOTO UNIV, INST VIRUS RES, DEPT VIRAL ONCOL, LAB HUMAN TUMOR VIRUSES, KYOTO 606, JAPAN
关键词
D O I
10.1006/bbrc.1997.6818
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently developed a hepatitis C virus (HCV) replication system using two cultured human cell lines: MT-BC, a human T-cell leukemia virus type I-infected cloned T cell line, and PH5CH, a non-neoplastic human hepatocyte line. In the course of the study, we found evidence that replication of hepatitis G virus (HGV), which has recently been identified, was supported in both MT-2C and PH5CH cells. When these cells were inoculated with serum 1B-3 containing both HCV and HGV obtained from a blood donor, the 5'-noncoding (5'-NC) regions of HCV RNA and HGV RNA were detected by RT-nested PCR in both cell lines more than 30 days postinoculation, and the 3'-noncoding region of HGV RNA was also detected in the both cell lines more than 30 days postinoculation. Sequence analysis of the 5'-NC region of HGV RNA revealed the quasispecies nature of HGV, although the 5'-NC region was highly conserved among HGV isolates. This HGV-infected culture system will be useful for various biological and virological studies of HGV. (C) 1997 Academic Press.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 24 条
[1]   Hepatitis G infection in drug abusers with chronic hepatitis C [J].
Aikawa, T ;
Sugai, Y ;
Okamoto, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :195-196
[2]   Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection [J].
Alter, MJ ;
Gallagher, M ;
Morris, TT ;
Moyer, LA ;
Meeks, EL ;
Krawczynski, K ;
Kim, JP ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (11) :741-746
[3]   Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus [J].
Berg, T ;
Dirla, U ;
Naumann, U ;
Heuft, HG ;
Kuther, S ;
Lobeck, H ;
Schreier, E ;
Hopf, U .
JOURNAL OF HEPATOLOGY, 1996, 25 (05) :763-768
[4]   Nucleotide sequence of the 5' noncoding region of hepatitis G virus isolated from Japanese patients: Comparison with reported isolates [J].
Fukushi, S ;
Kurihara, C ;
Ishiyama, N ;
Okamura, H ;
Hoshino, FB ;
Oya, A ;
Katayama, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 226 (02) :314-318
[5]  
IKEDA M, 1997, IN PRESS J HEPATOL
[6]  
KAGEYAMA T, 1996, ACTA HEPATOL JAP, V38, P178
[7]   Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes [J].
Kato, N ;
Ikeda, M ;
Mizutani, T ;
Sugiyama, K ;
Noguchi, M ;
Hirohashi, S ;
Shimotohno, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (08) :787-792
[8]   MARKED SEQUENCE DIVERSITY IN THE PUTATIVE ENVELOPE PROTEINS OF HEPATITIS-C VIRUSES [J].
KATO, N ;
OOTSUYAMA, Y ;
TANAKA, T ;
NAKAGAWA, M ;
NAKAZAWA, T ;
MURAISO, K ;
OHKOSHI, S ;
HIJIKATA, M ;
SHIMOTOHNO, K .
VIRUS RESEARCH, 1992, 22 (02) :107-123
[9]   SUSCEPTIBILITY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTED CELL-LINE MT-2 TO HEPATITIS-C VIRUS-INFECTION [J].
KATO, N ;
NAKAZAWA, T ;
MIZUTANI, T ;
SHIMOTOHNO, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (03) :863-869
[10]  
Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt